NATURECELL CO.,LTD.
KOSDAQ-listed regenerative medicine company developing the stem cell therapeutics Jointstem and Astrostem.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1971 and listed on KOSDAQ in 1992, NatureCell is a regenerative medicine company developing stem cell therapeutics derived from autologous adipose tissue. It is conducting U.S. clinical development of Jointstem, a treatment for degenerative arthritis, and Astrostem, a treatment for Alzheimer's dementia, while also selling the stem cell culture-derived cosmetics line Dr.Jucre and vegan beverages such as Sigolzip Oat Sikhye and Fermented Red Ginseng K. Jointstem has received U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy Designation (BTD); of the company's consolidated revenue of approximately KRW 20.7 billion for the period, the stem cell business accounted for 57% and the food business for 41%.
Products & technology
- JointstemStem cell therapy for degenerative arthritis
- AstrostemStem cell therapy for Alzheimer's dementia
- Dr.JucreStem cell culture-derived cosmetics
- Vegan beverages (Sigolzip Oat Sikhye, Fermented Red Ginseng K, Graviola K)Health-oriented vegan beverages and OEM products
Clinical trials
data.go.kr1 MFDS clinical trial authorisations · 2024 (Phase 2b/3 1)
- Phase 2b/3조인트스템2024-09-30
5 trial sites
R&D and key agreements
Source: DART corporate disclosure조인트스템 · 퇴행성관절염 · 국내 2b/3상 완료, 미국 2b/3a상 임상 진행중 · 5-year long-term follow-up completed; FDA RMAT and BTD designated
아스트로스템 · 알츠하이머성 치매 · 미국 1/2a상 완료, 미국 2b상 임상시험계획 승인 · Joint clinical development with Albio; 50% of sales revenue upon approval
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition